Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Aung Naing Razelle Kurzrock Gerald Falchook Apostolia Maria Tsimberidou |
| Publication date | August 20, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |